Crediti Commerciali Cambiamento Data
AstraZeneca USD 18.86B 972M 2026-06
Genmab DKK 1.22B 192M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
GRIFOLS EUR 1.19B 231M 2026-06
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Lakefront Biotherapeutics EUR 149.47M 95.44M 2026-06
Qiagen NV USD 398.35M 1.73M 2026-06
UCB EUR 1.97B 54M 2025-12